IRadimed Corp.

68
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US46266A1097
USD
93.92
1.86 (2.02%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
IRadimed Corp. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
24.00
21.00
16.00
9.00
0.00
9.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
3.00
-5.00
-5.00
-1.00
-1.00
-1.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
25.00
13.00
10.00
11.00
5.00
10.00
Cash Flow from Investing Activities
-8.00
-8.00
-1.00
0.00
0.00
3.00
Cash Flow from Financing Activities
-14.00
-13.00
-12.00
0.00
0.00
2.00
Net Cash Inflow / Outflow
2.00
-8.00
-4.00
11.00
6.00
15.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of IRadimed Corp.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
24.275459
-34.101
58.00
171.19%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
3.74892
-11.053
14.00
133.92%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
25.624463
-35.567
60.00
172.05%
Cash Flow from Investing Activities
-8.816786
-0.073
-8.00
-11977.79%
Cash Flow from Financing Activities
-14.335968
-4.964
-10.00
-188.80%
Net Cash Inflow / Outflow
2.471709
-40.604
42.00
106.09%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 90.30% vs 34.08% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
25.62
13.47
90.30%